(Q34100819)

English

Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: systematic review of randomized trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: systematic review of randomized trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

peginterferon alfa-2b

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

object named as

Tahany Awad

1

0 references

Christian Gluud

object named as

Christian Gluud

6

0 references

object named as

Goran Hauser

3

0 references

object named as

Davor Stimac

4

0 references

Kristian Thorlund

2

object named as

Kristian Thorlund

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Mahasen Mabrouk

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1176-1184

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Diagnosis, management, and treatment of hepatitis C: an update

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Contradicted and initially stronger effects in highly cited clinical research

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Why most published research findings are false

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Randomized study of peginterferon-alpha2a plus ribavirin vs peginterferon-alpha2b plus ribavirin in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Peg-interferon alpha-2a versus Peg-interferon alpha-2b in nonresponders with HCV active chronic hepatitis: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Peginterferon alfa-2a plus ribavirin is more effective than peginterferon alfa-2b plus ribavirin for treating chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Effect of hepatitis C virus and its treatment on survival

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Hepatology may have problems with putative surrogate outcome measures

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Publication of clinical trials supporting successful new drug applications: a literature analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Registering clinical trials.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Outcome reporting in industry-sponsored trials of gabapentin for off-label use

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1).

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23504

21 January 2018

Identifiers

10.1002/HEP.23504

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34100819&oldid=1590465325"